---
title: "Haisco Pharma Gets Nod for Myasthenia Gravis Drug Trial"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264134306.md"
description: "Haisco Pharma Gets Nod for Myasthenia Gravis Drug Trial"
datetime: "2025-11-04T04:05:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264134306.md)
  - [en](https://longbridge.com/en/news/264134306.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264134306.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/264134306.md) | [繁體中文](https://longbridge.com/zh-HK/news/264134306.md)


# Haisco Pharma Gets Nod for Myasthenia Gravis Drug Trial



### Related Stocks

- [Haisco (002653.CN)](https://longbridge.com/en/quote/002653.CN.md)

## Related News & Research

- [Haisco Pharmaceutical Group Gets IND Acceptance for New Prostate Cancer Drug Combinations](https://longbridge.com/en/news/270570277.md)
- [Haisco Pharmaceutical Gets Acceptance for Investigational New Drug Application for Muscular Dystrophy Indication](https://longbridge.com/en/news/260549058.md)
- [InSilico Out-licensed Drug ISM4808 Begins Clinical Trial](https://longbridge.com/en/news/278010381.md)
- [AstraZeneca and Daiichi secure US fast-track status for cancer drug](https://longbridge.com/en/news/278343765.md)
- [HUTCHMED to Withdraw Cancer Drug TAZVERIK in Greater China After Ipsen Safety Move](https://longbridge.com/en/news/278365432.md)